These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19796683)

  • 1. Flowability characterisation of drug-excipient blends using a novel powder avalanching method.
    Nalluri VR; Kuentz M
    Eur J Pharm Biopharm; 2010 Feb; 74(2):388-96. PubMed ID: 19796683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entrainment of lactose inhalation powders: a study using laser diffraction.
    Watling CP; Elliott JA; Cameron RE
    Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a robust procedure for assessing powder flow using a commercial avalanche testing instrument.
    Hancock BC; Vukovinsky KE; Brolley B; Grimsey I; Hedden D; Olsofsky A; Doherty RA
    J Pharm Biomed Anal; 2004 Sep; 35(5):979-90. PubMed ID: 15336345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating.
    Huang Z; Scicolone JV; Han X; Davé RN
    Int J Pharm; 2015 Jan; 478(2):447-55. PubMed ID: 25475016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of particle properties on the flowability of ibuprofen powders.
    Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T
    Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precipitated silica as flow regulator.
    Müller AK; Ruppel J; Drexel CP; Zimmermann I
    Eur J Pharm Sci; 2008 Aug; 34(4-5):303-8. PubMed ID: 18595668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
    Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P
    Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas-pressurized dispersive powder flow tester for low volume sample characterization.
    Majid AM; Wong TW
    Int J Pharm; 2013 May; 448(1):150-8. PubMed ID: 23506957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of bulk powder flow performance using comprehensive particle size and particle shape distributions.
    Yu W; Muteki K; Zhang L; Kim G
    J Pharm Sci; 2011 Jan; 100(1):284-93. PubMed ID: 20572055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of shear intensity and total shear on properties of blends and tablets of lactose and cellulose lubricated with magnesium stearate.
    Mehrotra A; Llusa M; Faqih A; Levin M; Muzzio FJ
    Int J Pharm; 2007 May; 336(2):284-91. PubMed ID: 17236729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders.
    Kwan CC; Chen YQ; Ding YL; Papadopoulos DG; Bentham AC; Ghadiri M
    Eur J Pharm Sci; 2004 Dec; 23(4-5):327-36. PubMed ID: 15567285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance.
    Cordts E; Steckel H
    Eur J Pharm Biopharm; 2012 Oct; 82(2):417-23. PubMed ID: 22902789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier.
    Hassan MS; Lau R
    Int J Pharm; 2010 Feb; 386(1-2):6-14. PubMed ID: 19922775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward better understanding of powder avalanching and shear cell parameters of drug-excipient blends to design minimal weight variability into pharmaceutical capsules.
    Nalluri VR; Puchkov M; Kuentz M
    Int J Pharm; 2013 Feb; 442(1-2):49-56. PubMed ID: 22917747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shear-induced APAP de-agglomeration.
    Llusa M; Levin M; Snee RD; Muzzio FJ
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1487-95. PubMed ID: 19929208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.